Recent Reports


2011-11-14: Biotechnology and Pharmaceuticals Report
5 leading Analysts; and top management from 4 Sector Firms examine this industry.
Order this Report
More Information

2011-10-31: Health Care IT Report
4 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-10-17: Medical Research, Diagnostic Substances & Life Science Tools Report
4 leading Analysts; and top management from 3 Sector Firms examine this industry.
Order this Report
More Information

2011-10-03: Medical Real Estate Report
3 leading Analysts; and top management from 3 Sector Firms examine industry.
Order this Report
More Information

2011-07-11: Medical Devices Report
5 leading Analysts; and top management from 12 Sector Firms examine this industry.
Order this Report
More Information

2011-06-27: Health Care IT Report
6 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

2011-06-13: Medical Research, Diagnostic Substances & Life Science Tools Report
5 leading Analysts; and top management from 3 Sector Firm examine this industry.
Order this Report
More Information

2011-04-04: Biotechnology and Pharmaceuticals Report
3 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-01-24: Medical Devices Report
3 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Company Interview Excerpt
NBTY, Inc. - Harvey Kamil


Full article published: 04/05/2010


For Subscribers

Get this article online now!

Order just this article
TWST: Introduce us to NBTY and give us a history of your operations.
Mr. Kamil: NBTY was started in 1971. We've been public since then, so we have a lot of years of experience. We are a marketer and manufacturer of nutritional supplements, and we have four channels of distribution. We have a North American retail operation, a European retail operation, an operation that we call Direct Response/E-Commerce, so it's a mail order operation. Lastly, we have a wholesale operation. In most of the fields we're in, we are the lead player, with the exception of North American retail operation. In the other three channels, we're the lead player.

TWST: And you have more than 22,000 products?
Mr. Kamil: Yes, but actually what it is, we carry about more than 2,000 formulas. When we say 22,000 products, I think a better explanation would be what we call stock-keeping units, or better known as SKUs. Because we have such a broad array of customers, we have different labels to supply those customers products.

 

Tickers included in this excerpt: NTY

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.